Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 1 recruiting now early-phase tilt small index

Narcotic Use: early-phase trial registry

1 of 4 indexed Narcotic Use trials are currently recruiting, with more weight in Phase 1-2.

Corpus placement: #4,115 of 28,707 conditions by registered trial count.

4 US clinical trials · 1 currently recruiting · #4,115 of 28,707 conditions by registered trial count

Narcotic Use: 4 US clinical trials tracked, 1 recruiting.

Narcotic Use is the subject of 4 registered US clinical trials on ClinicalTrials.gov, 1 of them currently open to new participants. 0 are in Phase 3-4 (later-stage) and 3 in Phase 1-2 (earlier-stage). The most active sponsor is St. Louis University, running 1 of these trials.

Enrollment posture brief

Registry condition narcotic-use

OPEN 1 | RECR 25% | LATE 0 | EARLY 3 | RANK #4115 | SPON 1

Nearest open-share peer: Abdominal Cancer (25% recruiting · 8 trials)

Ablation80%ACL Reconstruction80%Abuse, Drug60%Acceptability60%Narcotic Use (this)25%
Open-enrollment share among volume-matched conditions near Narcotic Use

Narcotic Use lists 1 open slots (25% of 4 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Narcotic Use on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Narcotic Use is recruiting below its size-band peers.

    1 of 4 indexed trials (25%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

Phase 11Phase 22

Phase Distribution

PhaseTrial count
Phase 1 1
Phase 2 2

Named interventions

Most-linked intervention names on Narcotic Use records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

Placebo regional nerveblock with normal saline Other
1 trials
regional nerve block with local anesthesia of bupivacaine with steroid Drug
1 trials
Carbidopa-Levodopa 25 Mg-100 Mg Oral Tablet Drug
1 trials
Hydrocodone-Acetaminophen Drug
1 trials
Opioids Drug
1 trials
Naproxen 500 Mg Drug
1 trials
Gabapentin Drug
1 trials
Questionnaire Other
1 trials

US sites by state

Facility locations filed on Narcotic Use trials. A trial with sites in several states counts in each.

Missouri 1 trials
Michigan 1 trials
Illinois 1 trials
Alabama 1 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Narcotic Use page

4 registered trials, 1 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Narcotic Use condition card totals 4 registered trials; most-linked intervention Placebo regional nerveblock with normal saline; top US site state Missouri. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.